This profile was last updated on //
Is this you? Claim your profile.
675 West Kendall Street
Genzyme Corporation (Genzyme) is a biotechnology company. The Company�s product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease. Genzyme operates in four business segm
Find other employees at this company (8,514)
(195 Total References)
Bo Piela, +1 ...
Bo Piela, +1 617-768-6579
Bo Piela, ...
Bo Piela, +1-617-768-6579
Vice President, Corporate Communications
United Pompe Foundation
The program to develop Myozyme was the largest in our 25-year history,says Bo Piela, spokesperson for Genzyme.
There were many children who didn't meet the strict criteria for the clinical trials, but for whom we believed Myozyme would be helpful, says Piela, the Genzyme spokesperson.
Our expanded access program was approved to provide the therapy to these other patients before the FDA
had given their official approval.
Many of these patients began their therapy at Duke.
That way there was no delay in starting the treatment, and once the local institution was ready, Duke
could transfer the patient.
The expanded access program was resource intensive.
We had to train staff at each institution that agreed to participate.
Often that meant submitting a protocol and informed-consent form, and training staff all for one patient, says Piela
Some employees from other divisions of ...
Some employees from other divisions of Paris-based Sanofi, Genzyme's parent company, will move to the new building as well, Genzyme spokesman Bo Piela said.